KYMERA THERAPEUTICS, INC. Increase (Decrease) in Due from Related Parties
KYMERA THERAPEUTICS, INC. (KYMR) reported Increase (Decrease) in Due from Related Parties of $20.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for the quarter ending 2025-12-31 was $0.00.
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for the quarter ending 2025-09-30 was -$40.00M.
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for the quarter ending 2025-06-30 was $40.00M.
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for the quarter ending 2025-03-31 was $0.00.
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for fiscal 2025 was $0.00.
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for fiscal 2024 was -$15.00M, a 200.00% decline from fiscal 2023.
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for fiscal 2023 was $15.00M.
- KYMERA THERAPEUTICS, INC. increase (decrease) in due from related parties for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.00M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$40.00M derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | -$40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $40.00M 10-Q · filed 2026-08-05 | $40.00M derived: sum of 3 quarters · filed 2026-08-05 | $40.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | -$15.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | -$15.00M 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$15.00M 10-Q · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$15.00M 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.00M derived: sum of 2 quarters · filed 2026-02-26 | $15.00M derived: sum of 3 quarters · filed 2026-02-26 | $15.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$904.00K derived: sum of 2 quarters · filed 2024-02-22 | -$856.00K derived: sum of 3 quarters · filed 2024-02-22 | -$577.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | -$904.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$856.00K derived: sum of 2 quarters · filed 2022-11-03 | -$577.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $327.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $279.00K 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $577.00K 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$148.00K 10-K · filed 2022-02-24 | ||
| 2019-09-30 | -$148.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |